Heterocyclic derivatives in the treatment of Ischaemia and related diseases
US5428037A · kind A · utility
30Cited by
5References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 1993 |
| Grant date | Jun 27, 1995 |
| Priority date | — |
| Expiry date | Apr 9, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the formula: ##STR1## wherein A, R.sup.1, R.sup.2, R.sup.3 and m are defined as in the specification or a pharmaceutically acceptable acid addition salt or N-oxide thereof, are calcium and sodium channel antagonists useful for treating mammals having a variety of disease states, such as stroke, epilepsy, hypertension, angina, migraine, arrhythmia, thrombosis, embolism, and also for treatment of spinal injuries.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.